EPIGENOMICS AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.512 EUR | -0.26% |
|
+0.27% | -41.03% |
| 30/04 | Epigenomics AG Announces Jens Ravens Leaves as Executive Board Member | CI |
| 14/03 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 814.88Cr | - | |||||
| 359.64Cr | - | |||||
| 226.94Cr | - | |||||
| 190.05Cr | - | - | - | - | - | |
| 172.01Cr | - |
